CB
MRNA icon

CNB Bank’s Moderna MRNA Stock Holding History

CNB Bank’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2
Closed -$55 – 533
2025
Q2 		$55 Hold
2
– – ﹤0.01% 500
2025
Q1 		$57 Hold
2
– – ﹤0.01% 489
2024
Q4 		$83 Hold
2
– – ﹤0.01% 494
2024
Q3 		$134 Buy
+2
New +$184 ﹤0.01% 515
2022
Q1 		– Sell
-100
Closed -$25K – 517
2021
Q4 		$25K Hold
100
– – 0.01% 272
2021
Q3 		$38K Hold
100
– – 0.02% 246
2021
Q2 		$23K Hold
100
– – 0.01% 282
2021
Q1 		$13K Sell
100
-7
-7% -$1.01K 0.01% 309
2020
Q4 		$11K Buy
107
+7
+7% +$708 0.01% 316
2020
Q3 		$7K Hold
100
– – 0.01% 324
2020
Q2 		$6K Buy
+100
New +$5.48K 0.01% 355

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

CNB Bank's MRNA Position: Q3 2025 in Review

CNB Bank sold out of Moderna (MRNA) in Q3 2025, closing a stake of 2 shares — an estimated $55 sold.

CNB Bank first reported a position in MRNA in Q2 2020 and held it in 11 quarters. The position peaked at $38K in Q3 2021. 643 funds tracked by Wall St. Rank hold MRNA as of Q3 2025.

  • CNB Bank reported no remaining Moderna position as of Q3 2025 after selling out during the quarter.
  • CNB Bank sold 2 Moderna shares in Q3 2025, an estimated $55.
  • CNB Bank first reported a position in Moderna in Q2 2020 and held it in 11 quarters.
  • CNB Bank's Moderna position peaked at $38K in Q3 2021.
  • 643 funds tracked by Wall St. Rank held Moderna as of Q3 2025.

Based on CNB Bank's 13F filing for Q3 2025, filed 30 Oct 2025.